• <table id="gigg0"></table>
  • west china medical publishers
    Author
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Author "余波" 4 results
    • 大鼠自體靜脈移植后內膜增生中Ⅰ、Ⅲ型前膠原mRNA及其蛋白的早期表達

      目的 探討靜脈移植后內膜增生早期的發生機制.方法 采用免疫組織化學、核酸原位雜交等方法,對大鼠靜脈移植后7天、14天、28天和42天內膜增生中的Ⅰ型、Ⅲ型[α1(Ⅰ)、α1(Ⅲ)]前膠原Mrna及Ⅰ型、Ⅲ型膠原蛋白的表達進行定位、半定量觀察.結果 與組織修復相關的膠原合成于術后7天出現,術后14天消失.術后14天起,α1(Ⅰ)、α1(Ⅲ)前膠原Mrna開始大量在增生內膜的平滑肌細胞中表達,并于術后28天達高峰(Plt;0.05),與相應膠原的表達呈同步增長.結論 靜脈移植后7天Ⅰ型、Ⅲ型膠原即開始在內膜增生中的平滑肌細胞內轉錄及合成,且與平滑肌細胞的增殖無關.提示防治靜脈移植后內膜增生至少應從術后14天開始,并應包括抑制細胞增殖及膠原合成兩個方面.

      Release date:2016-08-30 06:35 Export PDF Favorites Scan
    • 5-羥色胺綜合征一例

      Release date: Export PDF Favorites Scan
    • Research progress on neuroinflammatory mechanisms of blood-brain barrier damage and repair in ischemic stroke

      Ischemic stroke (IS) is one of the important diseases threatening human health. The occurrence and development of IS can trigger a series of complex pathophysiological changes, including damage to the blood-brain barrier, ion imbalance, oxidative stress, mitochondrial damage, which ultimately lead to the apoptosis and necrosis of nerve cells in the ischemic area. Impaired blood-brain barrier is a key factor for cerebral edema, hemorrhagic transformation and poor prognosis in patients with IS, and neuroinflammatory response plays an important role in the damage and repair of the blood-brain barrier. This article mainly focuses on the neuroinflammatory response mediated by glial cells, pro-inflammatory cytokines and matrix metalloproteinases and the related mechanisms of IS blood-brain barrier damage and repair, in order to provide new directions for the treatment of IS.

      Release date:2022-05-24 03:47 Export PDF Favorites Scan
    • A PROSPECTIVE STUDY ON WOUND-HEALING HYDROGEL IN TREATING CHRONIC VENOUS ULCER OF LOWER EXTREMITIES

      【Abstract】 Objective To study the outcome of wound-heal ing hydrogel in treating chronic venous ulcer of lowerextremities so as to find a new therapy. Methods From April 2007 to September 2007, 60 patients with chronic venous ulcer of lower extremities were randomly assigned to wound-heal ing hydrogel group (group A, 30 cases) and control group (normal sal ine, group B, 30 cases). In group A, there were 24 males and 6 females, aging (57.3 ± 6.8) years; the disease course was (2.9 ± 0.7) years; and the ulcer area was (3.4 ± 0.6) cm2. In group B, there were 20 males and 10 females, aging (60.1 ± 7.4) years; the disease course was (3.3 ± 0.9) years; and the ulcer area was (3.1 ± 0.4) cm2. There were no differences in age, area of ulcer and course of disease between two groups (P gt; 0.05). The area of ulcer was measured every week after the treatment, and the effect of treatmentwas evaluated after 15 days. Results The ulcer area of 7 days and 14 days after treatment was (2.6 ± 0.7) and (1.1 ± 0.2) cm2 in group A, and (2.8 ± 0.6) and (2.3 ± 0.7) cm2 in group B, respectively; showing no statistically significant differences 7 days after treatment (P gt; 0.05), and showing statistically significant difference 14 days after treatment between two groups (P lt; 0.05).The average heal ing time was (12.0 ± 1.7) days in group A, and (31.0 ± 2.9) days in group B, respectively, showing statisticallysignificant difference (P lt; 0.01). The results were excellent, good, fair and poor in 16, 9, 4 and 1 of group A , and were in 3, 9, 14 and 4 of group B, respectively; showing statistically significant difference (P lt; 0.01). Conclusion Wound-heal ing hydrogel is effective in treating chronic venous ulcer of lower extremities.

      Release date:2016-09-01 09:10 Export PDF Favorites Scan
    1 pages Previous 1 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南